WEX Q4 2022 revenue $618.6M (+24% YoY); adj EPS $3.44 beats guidance; FY23 outlook strong

WEX Inc.

2022-FY EPS reported $4.50 revenue$2,350,511,000

Q4 GAAP net income $88.7M ($2.02/diluted) vs loss of $11.8M a year ago; adjusted net income $152.8M ($3.44/diluted), up 33%.
Full year revenue $2.35B (+27%); adjusted EPS $13.53 (+48% YoY). Adjusted free cash flow $782.4M.
Q1 2023 guidance: revenue $600-610M, adj net income $3.15-$3.25/diluted. Full year 2023: revenue $2.43-2.47B, adj EPS $13.55-14.05.
Total volume rose 45% to $212B; travel purchase volume up 57%; health SaaS accounts grew 14% to 18.5M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

WEX Inc. reported three months and year ended December 31, 2022 results: revenue Total revenue for the fourth quarter of 2022 increased 24% to $618.6 million, net income net income attributable to shareholders for the fourth quarter of 2022 was $88.7 million, EPS $2.02 per diluted share.

Period: three months and year ended December 31, 2022
Revenue: Total revenue for the fourth quarter of 2022 increased 24% to $618.6 million
Net income: net income attributable to shareholders for the fourth quarter of 2022 was $88.7 million
EPS: $2.02 per diluted share
Result: reported results

Exact text from the filing

WEX Inc. Reports Fourth Quarter and Full Year 2022 Financial Results PORTLAND, Maine--(BUSINESS WIRE)--February 9, 2023--WEX Inc. (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today reported financial results for the three months and year ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

WEX Inc. filing history →

Source: SEC EDGAR

accession 0001157523-23-000219

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.